BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2625142)

  • 1. [The effect of pyrazidol and inkazan on the rotation behavior of rats].
    Mashkovskiĭ MD; Bogdanov MB; Bondarenko NA
    Farmakol Toksikol; 1989; 52(6):29-32. PubMed ID: 2625142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of the tetracyclic antidepressants pyrazidol and inkazan on the adrenergic nerve transmission in the rat vas deferens].
    Panasiuk LV; Arefolov VA; Andreeva NI; Raevskiĭ KS; Mashkovskiĭ MD
    Farmakol Toksikol; 1982; 45(1):13-7. PubMed ID: 6276226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The comparative influence of pyrazidol, inkazan and other antidepressant monoamine oxidase inhibitors on the pressor effect of tyramine].
    Andreeva NI; Golovina SM; Faermark MF; Shvarts GIa; Mashkovskiĭ MD
    Farmakol Toksikol; 1991; 54(2):38-40. PubMed ID: 1884793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative pharmacological study of the antidepressants pyrazidol, inkazan, caroxazone and imipramine].
    Andreeva NI
    Farmakol Toksikol; 1982; 45(4):9-13. PubMed ID: 6889985
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of antidepressants on benzodiazepine (diazepam and nitrazepam) effects].
    Mashkovskiĭ MD; Andreeva NI; Parshin VA
    Farmakol Toksikol; 1988; 51(4):16-9. PubMed ID: 2903832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The influence of the Soviet antidepressants pyrazidol and inkazan on the effects of clonidine].
    Kuksgaus NE; Golovina SM; Andreeva NI
    Farmakol Toksikol; 1991; 54(1):11-4. PubMed ID: 1860489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSC, an adenosine A(2A) receptor antagonist and MAO B inhibitor, reverses behavior, monoamine neurotransmission, and amino acid alterations in the 6-OHDA-lesioned rats.
    Aguiar LM; Macêdo DS; Vasconcelos SM; Oliveira AA; de Sousa FC; Viana GS
    Brain Res; 2008 Jan; 1191():192-9. PubMed ID: 18164694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition of brain monoamine oxidase in the rat by multiple pyrazidol administration].
    Verevkina IV; Asnina VV; Gorkin VZ; Mashkovskiĭ MD
    Biull Eksp Biol Med; 1985 May; 99(5):583-4. PubMed ID: 4005414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra.
    Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ
    Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of co-administration of subchronic lithium pretreatment and acute MAO inhibitors on extracellular monoamine levels and the expression of contextual conditioned fear in rats.
    Kitaichi Y; Inoue T; Nakagawa S; Izumi T; Koyama T
    Eur J Pharmacol; 2006 Feb; 532(3):236-45. PubMed ID: 16487506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.
    Ahmad M; Saleem S; Ahmad AS; Yousuf S; Ansari MA; Khan MB; Ishrat T; Chaturvedi RK; Agrawal AK; Islam F
    J Neurochem; 2005 Apr; 93(1):94-104. PubMed ID: 15773909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Selective inhibition by pyrazidol of monoamine oxidase type A in different human and animal tissues].
    Verevkina IV; Asnina VV; Gorkin VZ; Mashkovskiĭ MD
    Vopr Med Khim; 1983; 29(5):118-23. PubMed ID: 6649522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The new antidepressant tetrindole].
    Mashkovskiĭ MD; Glushkov RG; Shvedov VI; Andreeva NI; Golovina SM
    Eksp Klin Farmakol; 1993; 56(2):3-6. PubMed ID: 8348033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in the sensitivity of brain dopamine and serotonin receptors during the prolonged administration of carbidine].
    Zharkovskiĭ AM; Chereshka KS; Zharkovskaia TA; Allikmets LKh
    Biull Eksp Biol Med; 1985 Dec; 100(12):719-22. PubMed ID: 2866801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light-dark phase differences in behavioral effects of moclobemide in rats.
    Górka Z; Zajaczkowski W
    Pol J Pharmacol Pharm; 1991; 43(3):177-86. PubMed ID: 1961692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral effects of deprenyl in aged rats.
    Drago F; Continella G; Spadaro F; Cavaliere S; Scapagnini U
    Funct Neurol; 1986; 1(2):165-74. PubMed ID: 3111946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of (-) deprenyl (selegiline) on different behavioral changes induced by dopamine agonists in the rat.
    Timar J; Knoll B; Knoll J
    Pol J Pharmacol Pharm; 1988; 40(6):659-66. PubMed ID: 2908366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant-like effect of harmane and other beta-carbolines in the mouse forced swim test.
    Farzin D; Mansouri N
    Eur Neuropsychopharmacol; 2006 Jul; 16(5):324-8. PubMed ID: 16183262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine.
    Moroz IA; Peciña S; Schallert T; Stewart J
    Exp Neurol; 2004 Sep; 189(1):78-93. PubMed ID: 15296838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of piracetam on the action of antidepressants (experimental data)].
    Mashkovskiĭ MD; Andreeva NI; Parshin VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(2):129-31. PubMed ID: 2728714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.